On-demand content available for the IFCC Live Webinar "Common laboratory measures of dysglycaemia; their strengths and weaknesses"
Published: Monday, January 1, 0001
On-demand content available for the IFCC webinar
“Common laboratory measures of dysglycaemia;
their strengths and weaknesses”
Oct 27, 2021
Click here to access to your on-demand content
Dear Colleagues,
Diabetes Mellitus, and its precursor clinical syndromes, continue to grow in prevalence in developed and developing countries across the world. Clinical laboratory plays a crucial role in the diagnosis and management of diabetes to prevent short-term and long-term complications. Measurement of glucose, insulin, and HbA1c play vital roles in understanding and managing diabetes and over several decades laboratory professionals have improved their individual strengths, but also identified some significant weaknesses. No laboratory test is perfect, but it is vital that laboratory professionals are aware of any weaknesses and try to mitigate that risk so that the guidance that the laboratory provides to the clinician, and ultimately the patient, can be clear and balanced.
This seminar allowed the participant to identify the weaknesses with the measurement and reporting of glucose, insulin, and HbA1c, but also to recognize the laboratory techniques to minimize the risks associated with these weaknesses.
The webinar contained three presentations of 20 min per speaker plus 20 min panel discussion.
Talk 1: Laboratory measurement of glucose
Speaker: Greg Ward
Department Head Biochemistry
Sullivan Nicolaides Pathology, Brisbane, Queensland, AU
Talk 2: Insulin analysis in hyperglycemia
Speaker: Paul Williams
Principal Research Fellow
The University of Sydney (Central Clinical School), NSW, AU
Talk 3: HbA1c – still the gold standard?
Speaker: Ken Sikaris
Director of Chemical Pathology
Melbourne Pathology, Melbourne, Victoria, AU
Chairperson: Dr. Tina Yen,
Chemical Pathologist
St George Hospital, Kogarah, NSW, AU
Certificate of Participation: available for all participants. Please
The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital
